


Empaa L 5/25mg Tablets – Dual Therapy for Type 2 Diabetes
Pay in 3 Installments of
Rs.
483
Description
Empaa L 5/25mg Tablets – Dual-Action Treatment for Type 2 Diabetes
Prescription Required. Available at Derma.pk with valid prescription.
Empaa L 5/25mg Tablets is a fixed-dose combination prescription medicine containing Empagliflozin 25mg (SGLT2 inhibitor) and Linagliptin 5mg (DPP-4 inhibitor) for management of Type 2 diabetes mellitus in adults. This higher-strength empagliflozin formulation provides robust glycaemic control through complementary dual mechanisms in a single daily tablet.
Empagliflozin 25mg promotes urinary excretion of excess glucose through the kidneys for effective blood sugar lowering, while Linagliptin enhances insulin secretion by protecting incretin hormones from degradation. This combination is suitable for patients who require both SGLT2 and DPP-4 inhibition and who can tolerate the higher empagliflozin dose.
The combination provides additional cardiovascular and renal protective benefits as observed in clinical studies. It must only be used under the direction of a licensed physician or endocrinologist. Not suitable for Type 1 diabetes or patients with significantly reduced kidney function (eGFR below 30).
How to Order Empaa L 5/25mg at Derma.pk
Order Empaa L 5/25mg Tablets at Derma.pk, Pakistan's trusted online pharmacy. Browse our full anti-diabetic medicines range. A valid prescription is required. Contact us at sales@derma.pk or WhatsApp +92-320-5999650.
Usage & Benefits
- Higher-strength Empagliflozin 25mg with Linagliptin 5mg for stronger T2DM control.
- SGLT2 inhibition promotes urinary glucose excretion to lower blood sugar.
- DPP-4 inhibition enhances insulin secretion via incretin pathway support.
- Cardiovascular and renal protective benefits observed in clinical studies.
- Once-daily fixed-dose combination for patients needing stronger empagliflozin therapy.
How To Use
1. Use as directed by your physician or endocrinologist.
2. Take once daily, with or without food.
3. Swallow whole with a glass of water. Do not crush or chew.
4. Monitor blood glucose levels regularly as prescribed by your doctor.
5. Do not stop or adjust dosage without consulting your healthcare provider.
FAQs
What is Empaa L 5/25mg used for?
It is a prescription dual-action medicine for Type 2 diabetes with Empagliflozin 25mg and Linagliptin 5mg.
How does it differ from Empaa L 10/5mg?
This formulation contains the higher 25mg dose of Empagliflozin, suitable for patients requiring stronger SGLT2 inhibition.
When should I expect results?
Blood glucose lowering begins within days; significant HbA1c reduction is typically seen over 2–3 months of consistent use.
Can Empaa L 5/25mg be used for Type 1 diabetes?
No. It is indicated only for adults with Type 2 diabetes mellitus. Not for use in T1DM or eGFR below 30.
What are possible side effects?
Urinary tract infections, dehydration, and hypoglycemia (when combined with other agents) are possible. Always use under medical supervision.
